C. Wang

863 total citations
17 papers, 121 citations indexed

About

C. Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, C. Wang has authored 17 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in C. Wang's work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Diagnosis and Treatment (6 papers). C. Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Diagnosis and Treatment (6 papers). C. Wang collaborates with scholars based in China, United States and France. C. Wang's co-authors include Dongsheng Yue, Wenxin Wang, Fan Bai, Chang Chen, Huai Liu, Qing Chen, Dongzhi Hu, Jian Zhang, Raphael Thomadsen and Song Yao and has published in prestigious journals such as Management Science, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

C. Wang

17 papers receiving 119 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Wang China 6 82 73 14 11 9 17 121
Michela Libertini Italy 4 22 0.3× 50 0.7× 10 0.7× 15 1.4× 12 1.3× 13 81
Katharina Beyer United Kingdom 7 54 0.7× 64 0.9× 5 0.4× 22 2.0× 7 0.8× 29 153
Ana Sánchez Spain 8 33 0.4× 58 0.8× 18 1.3× 10 0.9× 24 2.7× 19 126
Sophie Marilier France 7 27 0.3× 90 1.2× 26 1.9× 14 1.3× 7 0.8× 13 132
Ofir Morag Israel 6 60 0.7× 69 0.9× 19 1.4× 15 1.4× 23 2.6× 14 133
Rachel Hunter‐Merrill United States 6 147 1.8× 91 1.2× 13 0.9× 24 2.2× 14 1.6× 11 210
Maite Martínez Aguillo Spain 9 92 1.1× 128 1.8× 23 1.6× 19 1.7× 18 2.0× 16 182
Lucía Viola Colombia 6 84 1.0× 49 0.7× 15 1.1× 10 0.9× 9 1.0× 22 133
Zoubida Zaidi Algeria 6 21 0.3× 61 0.8× 21 1.5× 21 1.9× 18 2.0× 17 131
Maria Francesca Vitale Italy 6 26 0.3× 60 0.8× 20 1.4× 12 1.1× 37 4.1× 6 116

Countries citing papers authored by C. Wang

Since Specialization
Citations

This map shows the geographic impact of C. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Wang more than expected).

Fields of papers citing papers by C. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Wang. The network helps show where C. Wang may publish in the future.

Co-authorship network of co-authors of C. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of C. Wang. A scholar is included among the top collaborators of C. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Wang. C. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
4.
5.
Provencio, Mariano, Patrick M. Forde, C. Wang, et al.. (2023). LBA57 Neoadjuvant nivolumab (N) + chemotherapy (C) in the phase III CheckMate 816 study: 3-y results by tumor PD-L1 expression. Annals of Oncology. 34. S1298–S1299. 13 indexed citations
6.
Yao, Song, et al.. (2023). The Impact of Government Interventions on COVID-19 Spread and Consumer Spending. Management Science. 70(5). 3302–3318. 5 indexed citations
7.
8.
Wang, C., Dongsheng Yue, Yuchen Ma, et al.. (2021). P60.06 Single Cell Sequencing Analysis Revealed Altered Lung Cancer Microenvironment by Neoadjuvant Immunotherapy. Journal of Thoracic Oncology. 16(3). S542–S543. 1 indexed citations
9.
10.
Wang, C., et al.. (2021). Nursing management at a Chinese fever clinic during the COVID‐19 pandemic. International Nursing Review. 68(2). 172–180. 15 indexed citations
11.
12.
Thomadsen, Raphael, et al.. (2020). The Impact of Social Distancing and Masking on COVID-19 Spread and Consumer Spending. SSRN Electronic Journal. 3 indexed citations
13.
He, Sisi, Meng Huang, Dongsheng Yue, et al.. (2019). P2.11-15 Detection of Circulating Genetically Abnormal Cells Improves the Diagnostic Accuracy in Lung Cancer Presenting with GGNs. Journal of Thoracic Oncology. 14(10). S798–S798. 1 indexed citations
14.
Lu, Shun, et al.. (2017). P1.04-010 CheckMate 870: An Open-label Safety Study of Nivolumab in Previously Treated Patients With Non-Small Cell Lung Cancer in Asia. Journal of Thoracic Oncology. 12(11). S1976–S1976. 1 indexed citations
15.
Liu, Hong, et al.. (2017). P2.03-040 EGFR T790M Mutation Detection and Osimertinib Treatment Response Evaluation by Liquid Biopsy in Advanced NSCLC Patients. Journal of Thoracic Oncology. 12(11). S2142–S2143. 1 indexed citations
16.
Yue, Dongsheng, Shidong Xu, Xueyong Li, et al.. (2017). OA 16.04 Efficacy and Safety of Erlotinib vs Vinorelbine/Cisplatin as Adjuvant Therapy for Stage IIIA EGFR Mutant NSCLC Patients. Journal of Thoracic Oncology. 12(11). S1789–S1789. 5 indexed citations
17.
Wang, C., et al.. (2015).  Identification of critical TF-miRNA-mRNA regulation loops for colorectal cancer metastasis. Genetics and Molecular Research. 14(2). 5485–5495. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michela Libertini Breakdown of academic impact, for papers by Katharina Beyer Breakdown of academic impact, for papers by Ana Sánchez Breakdown of academic impact, for papers by Sophie Marilier Breakdown of academic impact, for papers by Ofir Morag Breakdown of academic impact, for papers by Rachel Hunter‐Merrill Breakdown of academic impact, for papers by Maite Martínez Aguillo Breakdown of academic impact, for papers by Lucía Viola Breakdown of academic impact, for papers by Zoubida Zaidi Breakdown of academic impact, for papers by Maria Francesca Vitale
Rankless by CCL
2026